High Integrity Sample Storage Ensured By Double O-Ring Seal
Porvair Sciences has introduced new silicone cap mats for its range of 2 mL deep well storage blocks. Incorporating a novel double O-ring feature, the new silicone cap mats ensure a tight liquid proof seal every time. Such is the quality of the seal that capped storage blocks can be shaken, inverted or frozen without any loss of stored sample integrity.
Manufactured under class 10,000 clean room conditions from high grade silicone, which is resistant to most solvents, the new cap mats contain no contaminants that may leach out and affect stored sample. The new cap mats come with a specially weakened area in a shape of a cross on each of the 96 cap/well sections. For automated sample storage applications where piercing and reassessing is required the silicone cap mats allow easy, reproducible access while maintaining a high integrity seal on individual plate wells.
Silicone double O-ring cap mats are available for Porvair Sciences complete range of round and square well 2 mL storage blocks. All Porvair 96-well storage blocks are precisely made to ANSI / SLAS dimensions ensuring complete compatibility with almost all readers, washers and automated equipment.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.